The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses.
Isidoro FelicielloAlfredo ProcinoPublished in: Human vaccines & immunotherapeutics (2020)
We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection.